Literature DB >> 22907769

miR-21 represses FasL in microglia and protects against microglia-mediated neuronal cell death following hypoxia/ischemia.

Li Zhang1, Lian-Yan Dong, Ya-Jian Li, Zhen Hong, Wen-Shi Wei.   

Abstract

A growing body of evidence suggests that microRNA (miRNA) dysregulation contributes to many types of human disease, including central nervous system disorders. In this study, we identified an inverse correlation between the expression of miR-21 and Fas ligand (FasL) during hypoxia-induced microglial activation. Specifically, hypoxia caused the upregulation of FasL expression but the downregulation of miR-21 expression in microglia. Furthermore, we demonstrated that miR-21 suppresses FasL production by directly binding to its 3'-untranslated region. The overproduction of FasL following hypoxic microglial activation induced neuronal apoptosis, whereas the ectopic expression of miR-21 partially protected neurons from cell death caused by hypoxia-activated microglia. Finally, we confirmed that the function of miR-21 in microglia-mediated neuronal injury is dependent on FasL. Our study demonstrates an important role for miRNAs in microglia-mediated neuronal apoptosis, and suggests potential novel therapeutic interventions for cerebral hypoxic diseases associated with microglial activation.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22907769     DOI: 10.1002/glia.22404

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  49 in total

1.  Changes in microglial inflammation-related and brain-enriched MicroRNAs expressions in response to in vitro oxygen-glucose deprivation.

Authors:  Huimin Kong; Ahmed Omran; Muhammad Usman Ashhab; Na Gan; Jing Peng; Fang He; Liwen Wu; Xiaolu Deng; Fei Yin
Journal:  Neurochem Res       Date:  2013-12-12       Impact factor: 3.996

Review 2.  All's well that transcribes well: non-coding RNAs and post-stroke brain damage.

Authors:  Raghu Vemuganti
Journal:  Neurochem Int       Date:  2013-08-15       Impact factor: 3.921

Review 3.  Epigenetics and the modulation of neuroinflammation.

Authors:  Gwenn A Garden
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 4.  Roles of microglia in brain development, tissue maintenance and repair.

Authors:  Mackenzie A Michell-Robinson; Hanane Touil; Luke M Healy; David R Owen; Bryce A Durafourt; Amit Bar-Or; Jack P Antel; Craig S Moore
Journal:  Brain       Date:  2015-03-29       Impact factor: 13.501

Review 5.  MicroRNA-21 in the Pathogenesis of Traumatic Brain Injury.

Authors:  Wei Ji; Jiantong Jiao; Chao Cheng; Junfei Shao
Journal:  Neurochem Res       Date:  2018-07-31       Impact factor: 3.996

6.  MicroRNAs: New Players in Anesthetic-Induced Developmental Neurotoxicity.

Authors:  Danielle Twaroski; Zeljko J Bosnjak; Xiaowen Bai
Journal:  Pharm Anal Acta       Date:  2015

7.  MicroRNA Expression in the Glaucomatous Retina.

Authors:  Hari Jayaram; William O Cepurna; Elaine C Johnson; John C Morrison
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

8.  miR-30a-5p inhibition promotes interaction of Fas+ endothelial cells and FasL+ microglia to decrease pathological neovascularization and promote physiological angiogenesis.

Authors:  Salome Murinello; Yoshihiko Usui; Susumu Sakimoto; Maki Kitano; Edith Aguilar; H Maura Friedlander; Amelia Schricker; Carli Wittgrove; Yoshihiro Wakabayashi; Michael I Dorrell; Peter D Westenskow; Martin Friedlander
Journal:  Glia       Date:  2018-11-28       Impact factor: 7.452

9.  MicroRNA-27a Negatively Modulates the Inflammatory Response in Lipopolysaccharide-Stimulated Microglia by Targeting TLR4 and IRAK4.

Authors:  Yan-Ni Lv; Ai-Jun Ou-Yang; Long-Sheng Fu
Journal:  Cell Mol Neurobiol       Date:  2016-03-12       Impact factor: 5.046

Review 10.  MicroRNAs in the brain: it's regulatory role in neuroinflammation.

Authors:  Menaka C Thounaojam; Deepak K Kaushik; Anirban Basu
Journal:  Mol Neurobiol       Date:  2013-01-12       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.